Main > ENDOCRINOLOGY > Diabetes. Treatment > Insulin. Sensitizer. > Propanoic Acid Deriv (PPAR Agonist) > Aryl HydroxyPropanoic Acid Deriv. > TesiGlitazar. > Co.: UK. A (Development/Patent)



Co.: UK. A (Development/Patent)'s subsections
Chemical Name
Company
Estimated MAA Filing: 2007
Estimated NDA Filing: 2007
Patent
PPAR Alpha & Gamma Agonist
Status: Phase III
TradeMark
UpDate: 07.28.2005

Co.: UK. A (Development/Patent)'s products
This section has no products